P3 Health Partners (PIII) EBITDA Margin (2021 - 2025)

P3 Health Partners (PIII) reported EBITDA Margin of 39.85% for Q4 2025, down 268.0% on a YoY basis from 23.72% in Q4 2024, and down 214.71% quarter-over-quarter from 12.66% in Q3 2025.

P3 Health Partners (PIII) EBITDA Margin (2021 - 2025) Analysis & Trends

P3 Health Partners has reported EBITDA Margin for 5 years, with the latest figure at 39.85% in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 268.0% year-over-year to 39.85%; the trailing twelve-month figure through Dec 2025 stood at 18.37% (up 284.0% YoY), and the FY2025 full-year result was 18.37%, up 284.0% from the prior year.
  • EBITDA Margin for Q4 2025 stood at 39.85%, down from 12.66% in the prior quarter.
  • The five-year high for EBITDA Margin was 258.96% in Q4 2021, with the low at 827.09% in Q1 2021.
  • Historically, EBITDA Margin has averaged 70.13% across 5 years, with a median of 17.98% in 2021.
  • The largest YoY upside for EBITDA Margin was 80824 bps in 2022 against a maximum downside of 32035 bps in 2022.
  • P3 Health Partners' EBITDA Margin stood at 258.96% in 2021, then tumbled by 180 bps to 207.56% in 2022, then surged by 91 bps to 18.38% in 2023, then sank by 102 bps to 37.18% in 2024, then dropped by 7 bps to 39.85% in 2025.
  • The last three EBITDA Margin figures came in at 39.85% (Q4 2025), 12.66% (Q3 2025), and 9.42% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn -2.96%
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 24.14%
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 14.11%
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 3.76%
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 8.99%
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 11.19%
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 4,926.74%
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 15.04%
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 8.45%
10 P3 Health Partners 35.57 Mn 24.77 Mn 384.48 Mn -39.85%

Historic Data

Download Data
DateValue
Dec 31, 2025 -39.85%
Sep 30, 2025 -12.66%
Jun 30, 2025 -9.42%
Mar 31, 2025 -10.04%
Dec 31, 2024 -37.18%
Sep 30, 2024 -29.38%
Jun 30, 2024 -8.11%
Mar 31, 2024 -11.15%
Dec 31, 2023 -18.38%
Sep 30, 2023 -11.56%
Jun 30, 2023 -6.21%
Mar 31, 2023 -15.96%
Dec 31, 2022 -207.56%
Sep 30, 2022 -23.89%
Jun 30, 2022 -338.31%
Mar 31, 2022 -18.85%
Dec 2, 2021 258.96%
Sep 30, 2021 -18.01%
Jun 30, 2021 -17.96%
Mar 31, 2021 -827.09%